News

Pharmaceutical companies will no longer be allowed to pay fees to Canadian doctors for overseeing intravenous infusions of their medications under a revised ethical code written by the industry group for brand-name drug makers. The goal is to remove incentives that encourage doctors to prescribe...

Canadians aged 65 and older were the only age group to report slightly higher rates of cannabis usage after the drug’s legalization, new Statistics Canada numbers show. Kelly Gorman, director of public policy and government affairs at the Arthritis Society, said cannabis is a hot topic at...